Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MS-551

Known as: MS 551 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
MS-551 is a newly synthesized, nonspecific K+ channel blocker. To elucidate its electrophysiological and potential proarrhythmic… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
1996
1996
OBJECTIVE The frequency-dependent effects of MS-551 on the action potential duration (APD) and the underlying ionic mechanisms… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1995
1995
We have studied the effects of MS-551 on the inward rectifier potassium channel (IK1) in isolated guinea-pig ventricular myocytes… Expand
1995
1995
To investigate the clinical effects of MS‐551, a Class III antiarrhythmic agent, 11 patients underwent electrophysiological study… Expand
1995
1995
Summary We studied the electrophysiologic and anti-fibrillatory properties of MS-551 (l,3-dimethyl-6-{(2-[N-hydroxy-ethyl)-3-(4… Expand
1995
1995
The antiarrhythmic effects of a new class III antiarrhythmic agent, MS-551 [1,3-dimethyl-6-(2-[N-(2-hydroxyethyl)-3-(4… Expand
1995
1995
The novel class III antiarrhythmic agent, MS-551, has recently been shown to attenuate the decrease in ventricular effective… Expand
1994
1994
Summary: We examined the effects of MS-551 (1,3-dimethyl-6-{(2-[N-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino]ethylamino} 2,4… Expand
Highly Cited
1993
Highly Cited
1993
1 Electrophysiological effects of MS‐551, a new class III antiarrhythmic drug, were examined and compared with those of… Expand
Highly Cited
1992
Highly Cited
1992
The antiarrhythmic effects of MS-551, which prolongs cardiac action potential duration without affecting the maximum upstroke… Expand